Home About us Contact
|
Home About us Contact | ||
|
|
||
Oldest Age (oldest + age)
Terms modified by Oldest Age Selected AbstractsCholine acetyltransferase activity at different ages in brain of Ts65Dn mice, an animal model for Down's syndrome and related neurodegenerative diseasesJOURNAL OF NEUROCHEMISTRY, Issue 2 2006Andrea Contestabile Abstract Ts65Dn mice, trisomic for a portion of chromosome 16 segmentally homologous to human chromosome 21, are an animal model for Down's syndrome and related neurodegenerative diseases, such as dementia of the Alzheimer type. In these mice, cognitive deficits and alterations in number of basal forebrain cholinergic neurons have been described. We have measured in Ts65Dn mice the catalytic activity of the cholinergic marker, choline acetyltransferase (ChAT), as well as the activity of the acetylcholine-degrading enzyme acetylcholinesterase (AChE), in the hippocampus and in cortical targets of basal forebrain cholinergic neurons. In mice aged 10 months, ChAT activity was significantly higher in Ts65Dn mice, compared to 2N animals, in the hippocampus, olfactory bulb, olfactory cortex, pre-frontal cortex, but not in other neocortical regions. At 19 months of age, on the other hand, no differences in ChAT activity were found. Thus, alterations of ChAT activity in these forebrain areas seem to recapitulate those recently described in patients scored as cases of mild cognitive impairment or mild Alzheimer's disease. Other neurochemical markers putatively associated with the disease progression, such as those implicating astrocytic hyperactivity and overproduction of amyloid precursor protein family, were preferentially found altered in some brain regions at the oldest age examined (19 months). [source] 39Ar- 40Ar chronology of R chondritesMETEORITICS & PLANETARY SCIENCE, Issue 3 2003Eleanor T. DIXON The 39Ar- 40Ar ages were determined on whole-rock samples of four R chondrites: Carlisle Lakes, Rumuruti, Acfer 217, and Pecora Escarpment #91002 (PCA 91002). All samples are breccias except for Carlisle Lakes. The age spectra are complicated by recoil and diffusive loss to various extents. The peak 39Ar- 40Ar ages of the four chondrites are 4.35, ,4.47 ± 0.02, 4.30 ± 0.07 Ga, and 4.37 Ga, respectively. These ages are similar to Ar-Ar ages of relatively unshocked ordinary chondrites (4.52,4.38 Ga) and are older than Ar-Ar ages of most shocked ordinary chondrites («4.2 Ga). Because the meteorites with the oldest (Rumuruti, ,4.47 Ga) and the youngest (Acfer 217, ,4.30 Ga) ages are both breccias, these ages probably do not record slow cooling within an undisrupted asteroidal parent body. Instead, the process of breccia formation may have differentially reset the ages of the constituent material, or the differences in their age spectra may arise from mixtures of material that had different ages. Two end-member type situations may be envisioned to explain the age range observed in the R chondrites. The first is if the impact(s) that reset the ages of Acfer 217 and Rumuruti was very early. In this case, the ,170 Ma maximum age difference between these meteorites may have been produced by much deeper burial of Acfer 217 than Rumuruti within an impact-induced thick regolith layer, or within a rubble pile type parent body following parent body re-assembly. The second, preferred scenario is if the impact that reset the age of Acfer 217 was much later than that which reset Rumuruti, then Acfer 217 may have cooled more rapidly within a much thinner regolith layer. In either scenario, the oldest age obtained here, from Rumuruti, provides evidence for relatively early (,4.47 Ga) impact events and breccia formation on the R chondrite parent body. [source] Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DMPEDIATRIC DIABETES, Issue 3 2010Ali Mohamadi Mohamadi A, Clark LM, Lipkin PH, Mahone EM, Wodka EL, Plotnick LP. Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM. Mutations in the KCNJ11 gene, which encodes the Kir6.2 subunit of the ATP-sensitive potassium channel, often result in neonatal diabetes. Patients with this mutation have been successfully transitioned from insulin to sulfonylurea (SU) therapy without compromise in their glycemic control. Among patients with neonatal diabetes due to KCNJ11 mutations, approximately 25% have neurological findings including developmental delay, motor dysfunction, and epilepsy, known as DEND syndrome. There have been rare cases of juvenile patients with intermediate DEND syndrome (iDEND) reporting variable improvement in neurological function following transition from insulin to SU treatment. We describe the response to glyburide in a 15-yr-old boy with severe global developmental delays resulting from the KCNJ11 mutation V59M. The patient was discovered to have diabetes mellitus at 11.5 months of age, making this the oldest age at diagnosis of a KCNJ11 mutation-related case of neonatal diabetes. Because consensus has been to screen patients for this mutation only if younger than 6 months at the time of diagnosis, we suggest that all patients under the age of 12 months at diagnosis should receive genetic testing for monogenic causes of diabetes. [source] Mortality differences by APOE genotype estimated from demographic synthesisGENETIC EPIDEMIOLOGY, Issue 2 2002Douglas C. EwbankArticle first published online: 10 JAN 200 Abstract The 4 allele of apolipoprotein E (APOE) is associated with increased risk of two major causes of death in low-mortality populations: ischemic heart disease and Alzheimer's disease. It is less common among centenarians than at younger ages. Therefore, it is likely that it is associated with excess risk of death. This article extends demographic models that estimate relative mortality risks from changes in gene frequencies with age. The resulting demographic synthesis combines gene frequencies with data on mortality by genotype from cohort studies. The model was applied to data from Denmark, Finland, France, Italy, Sweden, and the United States. Near age 50, the 3/4 genotype is associated with a risk of death of 1.34 times that of the 3/3 (95% CI 1.18,1.67). The relative risk for 4/4 is the square of the relative risk for 3/4, 1.81. The 2/3 genotype is protective with a relative risk of 0.84 (0.68,0.93) near age 50. These relative risks move toward 1.0 at the oldest ages and APOE genotype is associated with little variation in mortality over age 100. There are no significant differences in the relative risks by sex. There is little evidence of differences within Europe in the effects of APOE. This approach can be generalized to combine data on genetic risk factors for disease from a wide variety of study designs and sample characteristics. Genet. Epidemiol. 22:146,155, 2002. © 2002 Wiley-Liss, Inc. [source] The Implications of Increased Survivorship for Mortality Variation in Aging PopulationsPOPULATION AND DEVELOPMENT REVIEW, Issue 3 2010Michal Engelman The remarkable growth in life expectancy during the twentieth century inspired predictions of a future in which all people, not just a fortunate few, will live long lives ending at or near the maximum human life span. We show that increased longevity has been accompanied by less variation in ages at death, but survivors to the oldest ages have grown increasingly heterogeneous in their mortality risks. These trends are consistent across countries, and apply even to populations with record-low variability in the length of life. We argue that as a result of continuing improvements in survival, delayed mortality selection has shifted health disparities from early to later life, where they manifest in the growing inequalities in late-life mortality. [source] | ||||||||||